AXA PE acquires Riemser from TVM

The GP will continue to lead the company's international growth strategy and increased specialisation of its products.

Previous funding
TVM invested €18m for a 10% stake in Riemser in 2007. The firm helped the company internationalise, particularly in Asia, Western Europe and the Americas.

During the holding period, the company's turnover grew from €56m in 2006 to €100m at the time of exit. Its staff increased from 450 to 500.

Company
Riemser is based in Greifswald and was founded in 1991. The company focuses on the sales, marketing and lifecycle management of prescription-only human pharmaceuticals in selected markets, particularly oncology, anti-infectives, dermatology and dental. The company exports to 73 countries worldwide.

People
Christof Namenyi is managing director of AXA PE.

Advisers
Equity – Willkie Farr & Gallagher (Legal).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Healthcare
• Buyouts
• Secondary buyout
• Germany
• Axa Private Equity